Medtronic Plc Stock Current Liabilities
| MDTC34 Stock | BRL 245.59 0.00 0.00% |
Medtronic plc fundamentals help investors to digest information that contributes to Medtronic Plc's financial success or failures. It also enables traders to predict the movement of Medtronic Stock. The fundamental analysis module provides a way to measure Medtronic Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medtronic Plc stock.
Medtronic |
Medtronic plc Company Current Liabilities Analysis
Medtronic Plc's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Medtronic plc has a Current Liabilities of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The current liabilities for all Brazil stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Medtronic Fundamentals
| Return On Equity | 0.0833 | |||
| Return On Asset | 0.0422 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 625.84 B | |||
| Shares Outstanding | 2.66 B | |||
| Price To Earning | 52.06 X | |||
| Price To Book | 2.03 X | |||
| Price To Sales | 18.03 X | |||
| Revenue | 31.69 B | |||
| Gross Profit | 21.71 B | |||
| EBITDA | 8.78 B | |||
| Net Income | 5.04 B | |||
| Cash And Equivalents | 10.6 B | |||
| Cash Per Share | 3.94 X | |||
| Total Debt | 20.32 B | |||
| Debt To Equity | 0.50 % | |||
| Current Ratio | 2.89 X | |||
| Book Value Per Share | 19.50 X | |||
| Cash Flow From Operations | 7.35 B | |||
| Earnings Per Share | 8.13 X | |||
| Price To Earnings To Growth | 3.05 X | |||
| Number Of Employees | 95 K | |||
| Beta | 0.73 | |||
| Market Capitalization | 589.18 B | |||
| Total Asset | 90.98 B | |||
| Z Score | 17.4 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 90.98 B | |||
| Last Dividend Paid | 2.62 |
About Medtronic Plc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medtronic plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtronic Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtronic plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| NVDA | NVIDIA | |
| CRESY | Cresud SACIF y | |
| GOOG | Alphabet Inc Class C |
Additional Information and Resources on Investing in Medtronic Stock
When determining whether Medtronic plc is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock. Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Medtronic Stock refer to our How to Trade Medtronic Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.